Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria
- PMID: 19077312
- PMCID: PMC2630325
- DOI: 10.1186/1475-2875-7-253
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria
Abstract
Background: Molecular mechanisms involved in the pathogenesis of severe Plasmodium falciparum malaria (SM), are not yet fully understood. Both endothelin-1 (ET-1) and C-type natriuretic peptide (CNP) are produced by vascular endothelium and act locally as paracrine regulators of vascular tone, ET-1 being a potent vasoconstrictor and CNP having strong vasorelaxant properties.
Methods: Plasma levels of ET-1 and N-terminal fragments of CNP (NT-proCNP) were studied on admission and after 24 hours of treatment, using enzyme-linked-immunosorbent-assay (ELISA) technique, in Gabonese children with severe falciparum malaria (SM, n = 50), with uncomplicated malaria (UM, n = 39) and healthy controls (HC, n = 25).
Results: Compared to HC, malaria patients had significantly higher plasma levels of ET-1 and significantly lower levels of NT-proCNP (p < 0.001 and p < 0.024 respectively). Plasma levels of NT-proCNP were additionally decreased in SM patients compared to HC (p = 0.034), whereas UM was not significantly different to HC. In the SM group we found a trend towards lower ET-1 levels compared to UM (p = 0.085).
Conclusion: In the present study, an imbalance between the vasoconstricitve and vasorelaxant endothelium-derived substances ET-1 and CNP in the plasma of children with falciparum malaria is demonstrated, presumably in favor of vasoconstrictive and pro-inflammatory effects. These results may indicate involvement of ET-1 and CNP in malaria pathogenesis. Furthermore, results of lower ET-1 and CNP levels in SM may reflect endothelial cell damage.
Figures


Similar articles
-
Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.Antimicrob Agents Chemother. 2003 Jan;47(1):231-7. doi: 10.1128/AAC.47.1.231-237.2003. Antimicrob Agents Chemother. 2003. PMID: 12499196 Free PMC article. Clinical Trial.
-
Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children.Trans R Soc Trop Med Hyg. 2000 Mar-Apr;94(2):188-90. doi: 10.1016/s0035-9203(00)90272-4. Trans R Soc Trop Med Hyg. 2000. PMID: 10897366 Clinical Trial.
-
Correlations between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum malaria.Infect Genet Evol. 2007 Mar;7(2):147-54. doi: 10.1016/j.meegid.2006.07.001. Epub 2006 Aug 4. Infect Genet Evol. 2007. PMID: 16890498
-
Pyrimethamine/sulfadoxine for treating uncomplicated Plasmodium falciparum malaria in young children in Gabon.Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):578-9. doi: 10.1016/s0035-9203(97)90033-x. Trans R Soc Trop Med Hyg. 1997. PMID: 9463673 No abstract available.
-
Endothelin-1 and its role in the pathogenesis of infectious diseases.Life Sci. 2014 Nov 24;118(2):110-9. doi: 10.1016/j.lfs.2014.04.021. Epub 2014 Apr 26. Life Sci. 2014. PMID: 24780317 Free PMC article. Review.
Cited by
-
Brain Endothelium: The "Innate Immunity Response Hypothesis" in Cerebral Malaria Pathogenesis.Front Immunol. 2019 Jan 29;9:3100. doi: 10.3389/fimmu.2018.03100. eCollection 2018. Front Immunol. 2019. PMID: 30761156 Free PMC article. Review.
-
Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.Am J Pathol. 2010 Mar;176(3):1306-15. doi: 10.2353/ajpath.2010.090691. Epub 2010 Jan 28. Am J Pathol. 2010. PMID: 20110412 Free PMC article.
-
Cerebral Malaria Model Applying Human Brain Organoids.Cells. 2023 Mar 23;12(7):984. doi: 10.3390/cells12070984. Cells. 2023. PMID: 37048057 Free PMC article.
-
Endothelins in inflammatory neurological diseases.Pharmacol Ther. 2019 Feb;194:145-160. doi: 10.1016/j.pharmthera.2018.10.001. Epub 2018 Oct 3. Pharmacol Ther. 2019. PMID: 30291906 Free PMC article. Review.
-
Nitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malaria.PLoS Pathog. 2013;9(6):e1003444. doi: 10.1371/journal.ppat.1003444. Epub 2013 Jun 20. PLoS Pathog. 2013. PMID: 23818850 Free PMC article.
References
-
- World Health Organization (WHO) World malaria report 2005 http://www.rollbackmalaria.org/wmr2005/
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials